When DKK-1 activity was inhibited by either using neutralizing anti-DKK-1 antibodies or RNAi, an attenuation of the inhibitory effects of MSCs on tumor cell proliferation was observed [41,42,43]. The gene discussed is DKK1; the disease is neoplasm.